Sejal Amin Takes the Helm as Chief Technology Officer at Priceline
February 11, 2025 - 15:16
In a significant leadership change, Priceline has appointed Sejal Amin as its new Chief Technology Officer. With a wealth of experience in technology and product engineering, Amin will be responsible for steering the company's technological vision and overseeing its product development initiatives.
Amin brings a strong background in infrastructure and engineering, having previously held various senior roles in leading tech firms. Her expertise is expected to enhance Priceline's ability to innovate and improve its offerings in the highly competitive travel industry.
In her new role, Amin will focus on leveraging cutting-edge technology to enhance customer experiences and streamline operations. She expressed enthusiasm about joining Priceline, stating her commitment to driving technological advancements that align with the company's strategic goals.
This appointment marks a pivotal moment for Priceline as it aims to strengthen its position in the market and respond to the evolving needs of travelers worldwide.
MORE NEWS
July 1, 2025 - 12:35
Westville Library Receives Grant for Technology and Internet EnhancementsWESTVILLE — In an era where technology is rapidly transforming our daily lives, the Westville Public Library in Vermilion County is taking significant steps to modernize its services. The library...
June 30, 2025 - 22:18
Webstar Technology Group Secures Contract for "The Forge" Project in Downtown AtlantaWebstar Technology Group, a prominent player in real estate development and digital asset innovation, has officially placed its transformative project, `The Forge,` under contract in the heart of...
June 30, 2025 - 04:30
Voice-Based Risk Assessment Firm Secures $60 Million in Series D FundingClearspeed, a prominent player in the voice-based risk assessment technology sector, has successfully raised $60 million in its Series D funding round. This latest investment elevates the company`s...
June 29, 2025 - 04:10
First Patient Enrolled in Groundbreaking Study on MicroPulse Technology for DMEA significant milestone has been reached in a clinical study evaluating the effectiveness of MicroPulse technology as an adjunct to anti-VEGF therapy for patients suffering from diabetic macular...